Gene · 56829
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. | Front Oncol | 2023 | 38169859 | PubTator, text mining | PubMed |
| Natural history of Ebola virus disease in rhesus monkeys shows viral variant emergence dynamics and tissue-specific host responses. | Cell Genom | 2023 | 38169842 | PubTator, text mining | PubMed |
| Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. | Viruses | 2023 | 38140636 | PubTator, text mining | PubMed |
| CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution? | Int J Mol Sci | 2023 | 38139316 | PubTator, text mining | PubMed |
| TRIM25 dictates selective miRNA loading into extracellular vesicles during inflammation. | Sci Rep | 2023 | 38135735 | PubTator, text mining | PubMed |
| Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families. | Pathogens | 2023 | 38133344 | PubTator, text mining | PubMed |
| An integrated workflow for quantitative analysis of the newly synthesized proteome. | Nat Commun | 2023 | 38086798 | PubTator, text mining | PubMed |
| Proximal tubule cells in blood and urine as potential biomarkers for kidney disease biopsy. | PeerJ | 2023 | 38077419 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| The DNA glycosylase NEIL2 is protective during SARS-CoV-2 infection. | Nat Commun | 2023 | 38071370 | PubTator, text mining | PubMed |
| Constructing a T-Cell Receptor-Related Gene Signature for Prognostic Stratification and Therapeutic Guidance in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38067199 | PubTator, text mining | PubMed |
| Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection. | Nat Commun | 2023 | 38065956 | PubTator, text mining | PubMed |
| Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors. | J Gen Virol | 2023 | 38063292 | PubTator, text mining | PubMed |
| A novel tamanavirus (Flaviviridae) of the European common frog (Rana temporaria) from the UK. | J Gen Virol | 2023 | 38059479 | PubTator, text mining | PubMed |
| Positive selection analyses identify a single WWE domain residue that shapes ZAP into a super restriction factor. | bioRxiv | 2023 | 38045310 | PubTator, text mining | PubMed |
| Young infants display heterogeneous serological responses and extensive but reversible transcriptional changes following initial immunizations. | Nat Commun | 2023 | 38042900 | PubTator, text mining | PubMed |
| CRISPR-Cas12a-integrated transgenes in genomic safe harbors retain high expression in human hematopoietic iPSC-derived lineages and primary cells. | iScience | 2023 | 38034357 | PubTator, text mining | PubMed |
| Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition. | iScience | 2023 | 38025778 | PubTator, text mining | PubMed |
| MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors. | Viruses | 2023 | 38005883 | PubTator, text mining | PubMed |
| Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics. | Genes (Basel) | 2023 | 38002944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/56829/papers?page=6